U.S. markets close in 6 hours 4 minutes
  • S&P 500

    4,266.54
    +24.70 (+0.58%)
     
  • Dow 30

    34,154.89
    +280.65 (+0.83%)
     
  • Nasdaq

    14,379.50
    +107.77 (+0.76%)
     
  • Russell 2000

    2,316.59
    +13.12 (+0.57%)
     
  • Crude Oil

    72.68
    -0.40 (-0.55%)
     
  • Gold

    1,783.00
    -0.40 (-0.02%)
     
  • Silver

    26.17
    +0.05 (+0.21%)
     
  • EUR/USD

    1.1953
    +0.0020 (+0.17%)
     
  • 10-Yr Bond

    1.4780
    -0.0090 (-0.61%)
     
  • GBP/USD

    1.3922
    -0.0042 (-0.30%)
     
  • USD/JPY

    110.7520
    -0.2100 (-0.19%)
     
  • BTC-USD

    33,918.62
    -196.27 (-0.58%)
     
  • CMC Crypto 200

    815.88
    +29.27 (+3.72%)
     
  • FTSE 100

    7,116.39
    +42.33 (+0.60%)
     
  • Nikkei 225

    28,875.23
    +0.34 (+0.00%)
     

UPDATE 2-Denmark to reconsider exclusion of J&J and AstraZeneca shots

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

(Adds health minister)

COPENHAGEN, May 31 (Reuters) - Denmark's government on Monday asked the country's health authorities to reconsider a decision to exclude Johnson & Johnson's and AstraZeneca's COVID-19 shots from its vaccination programme.

The move was prompted by a two-week delay in the Danish vaccination programme to September due to delivery of fewer Moderna and CureVac vaccines than expected, Health Minister Magnus Heunicke said.

Denmark excluded the J&J and AstraZeneca vaccines over a potential link to a rare but serious form of blood clot.

"We are now further into the epidemic, and the vaccines from Johnson & Johnson and AstraZeneca have now been in use in Europe for some time, Heunicke said.

"There is a larger data base worldwide to assess the effect and side effects of the vaccines," he said.

The health authority found in early May that the benefits of using the COVID-19 vaccines did not outweigh the risk of causing the possible adverse effect in those who receive the vaccine.

Excluding the J&J vaccine, which accounts for around a third of Denmark's total contracted supplies of COVID-19 shots, delayed the country's vaccination calendar by up to four weeks, the health authority said.

Denmark had vaccinated 21% of its population as of Monday.

(Reporting by Jacob Gronholt-Pedersen; editing by David Evans and Giles Elgood)